Weight lifting may reduce physical function deterioration among breast cancer survivors
the ONA take:
According to findings published online early in the Journal of Clinical Oncology, researchers from the Perelman School of Medicine at University of Pennsylvania in Philadelphia have found that slowly progressive weight lifting compared with standard of care reduced the incidence of physical function deterioration among breast cancer survivors.
For the single-blind, 12-month, controlled trial, researchers enrolled 295 survivors of nonmetastatic breast cancer and randomly assigned them to twice-per-week slowly progressive weight lifting or standard of care.
Results showed that 16.3% of those in the control group experienced incident physical function deterioration after 12 months compared with 8.1% in the weight lifting group (P = 0.04). Researchers did not observe any serious or unexpected adverse events related to weight lifting.
The researchers note that future studies should compare efficacy of weight lifting with other exercises, such as brisk walking, in order to develop a confirmatory study aimed at identifying the best approach to preserving physical function among breast cancer survivors.
Breast cancer survivors may experience physical function deterioration, which may lead to bone fracture, disability, injurious falls, and premature death.
Slowly progressive weight lifting reduced the incidence of physical function deterioration among breast cancer survivors.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|